US2017260297A1PendingUtilityA1
Resorbable cellulose based biomaterial and implant
Assignee: DEPUY SYNTHES PRODUCTS INCPriority: Feb 22, 2012Filed: May 25, 2017Published: Sep 14, 2017
Est. expiryFeb 22, 2032(~5.5 yrs left)· nominal 20-yr term from priority
A61L 31/042A61L 31/148A61L 27/58A61L 27/20C08B 15/02
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure describes an implant for tissue replacement or augmentation including a resorbable non-pyrogenic porous body of irradiated oxidized cellulose, formed from a precursor reactive mixture of irradiated cellulose and an oxidizing agent, where the body forms a heterogeneous three-dimensional fibrillar network.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . An implant for soft tissue repair comprising:
an oxidized film of irradiated microbial cellulose; wherein the film is porous and resorbable; wherein the film has a hydrated state upon exposure to fluid; and, wherein the film in the hydrated state is configured to conform to a soft tissue surface.
3 . The implant of claim 2 , wherein the film has a cellulose content in the range of about 2 mg/cm 2 to about 15 mg/cm 2 .
4 . The implant of claim 2 , further comprising an active agent.
5 . The implant of claim 4 , wherein the film is configured as a scaffold for the active agent.
6 . The implant of claim 4 , wherein the active agent is impregnated within the film.
7 . The implant of claim 4 , wherein the active agent is coated onto the film.
8 . The implant of claim 2 , wherein the film comprises an active agent impregnated within the film, and wherein the film comprises an active agent coated onto the film.
9 . The implant of claim 2 , wherein the film in the hydrated state is configured to self-adhere to the soft tissue surface.
10 . The implant of claim 2 , wherein the implant is configured as a hemostat.
11 . The implant of claim 2 , further comprising a secondary implantable device.
12 . The implant of claim 11 , wherein the film is configured as a hemostat.
13 . The implant of claim 2 , wherein the film has an in vitro degradation rate in one week under simulated body fluid (SBF) conditions of about zero percent to about 90 percent.
14 . The implant of claim 2 , wherein the film has an in vitro degradation rate in four weeks under simulated body fluid (SBF) conditions of about 80 percent to about 100 percent.
15 . The implant of claim 2 , wherein the film has an in vitro degradation rate under simulated body fluid (SBF) conditions such that the film remains mechanically stable at least between 2 weeks to four weeks.
16 . The implant of claim 2 , wherein the film, in the hydrated state, has a burst strength in the range of about 3 N to about 30 N.
17 . A method for repair of a soft tissue comprising:
attaching a porous oxidized film of irradiated microbial cellulose to a surface of a soft tissue, wherein the film has a hydrated state upon exposure to fluid; wherein attaching the film in the hydrated state to the surface of the soft tissue conforms the film to the surface of the soft tissue; and, wherein, after attaching, the film in the hydrated state is self-adhering to the surface of the soft tissue.
18 . The method of claim 17 , wherein the film is configured as a hemostat.
19 . The method of claim 17 , wherein the film further comprises an active agent.
20 . The method of claim 19 , wherein the active agent is impregnated within the film.
21 . The method of claim 19 , wherein the active agent is coated onto the film.
22 . The method of claim 17 , wherein the film is resorbable, and has an in vitro degradation rate in four weeks under simulated body fluid (SBF) conditions of about 80 percent to about 100 percent.
23 . The implant of claim 17 , wherein the film, in the hydrated state, has a burst strength in the range of about 3 N to about 30 N.Join the waitlist — get patent alerts
Track US2017260297A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.